First genetically engineered malaria vaccine to enter human trials
Walter and Eliza Hall Institute scientists have created a weakened strain of the malaria parasite that will be used as a live vaccine against the disease. The vaccine, developed in collaboration with researchers from the US, Japan and Canada, will be trialled in humans from early next year.
Covance to Sell Its Interactive Voice and Web Response Services and Enter Into a Multi-Year Marketing Agreement with Phase Forward
PRINCETON, N.J., July 15 /PRNewswire-FirstCall/ -- Covance Inc. (NYSE: CVD ) today announced it has signed an agreement to sell its Interactive Voice & Web Response Services (IVRS/IWRS) business to Phase Forward (Nasdaq: PFWD ). In addition, Covance and Phase Forward have agree...
Mylan Announces Strategic Collaboration with Biocon to Enter the Global Generic Biologics Market
PITTSBURGH, June 29 /PRNewswire-FirstCall/ -- Mylan Inc. (Nasdaq: MYL ) today announced that it has executed a definitive agreement with Biocon Limited, a publicly traded company on the Indian stock exchanges, for an exclusive collaboration on the development, manufacturing, supply and commercia...
Glenmark's Novel Molecule for Diabetes, Melogliptin to Enter Phase III Trials
- Melogliptin continues to demonstrate potential to be the
best-in-class in achieving glycemic control with low incidence of
hypoglycemia and neutral effect on body weight
- Global Phase III trials likely to start by end 2009
- IND approved by USFD...
Pioneer Hi-Bred and Beck's Hybrids Enter into Research and Distribution Agreements
Growers Will Benefit From More Seed Options in the Marketplace.
Des Moines, Iowa, and Atlanta, Ind. (Vocus) June 17, 2009 –- Pioneer Hi-Bred , a DuPont business, and Beck’s Hybrids today announced they have entered into research and distribution agreeme...
AccuVein and GSABC Enter into Purchasing Agreement for Vein Illumination Device
GSABC to Offer Members AccuVein's AV300 to Help Ease Venipuncture Process
UnitedPharma Named Preferred Blood Center Distributor for AccuVein AV300
COLD SPRING HARBOR, N.Y., June 8 /PRNewswire/ -- AccuVein LLC today announced a three-year agreement with Group Services for America's Blood ...
PDI and The Medical Affairs Company Enter Exclusive Strategic Alliance
SADDLE RIVER, N.J. and KENNESAW, Ga., June 3 /PRNewswire-FirstCall/ -- Two leaders in the pharmaceutical contract services industry, PDI, Inc. (Nasdaq: PDII ), a provider of sales and marketing support to U.S. pharmaceutical companies, and The Medical Affairs Company (TMAC(R)), the leading provi...
Morphotek(R), Inc and Lonza Group Ltd Enter Into Manufacturing Services Agreement
Agreement Underscores Morphotek's Commitment to the Development of Farletuzumab for Ovarian Cancer
Agreement Highlights Lonza's Ability to Offer Specialty Development and Manufacturing Solutions
EXTON, Pa. and BASEL, Switzerland, May 19 /PRNewswire/ -- Morphotek(R), Inc., a subsidiary of...
Nerviano Medical Sciences Receives Approval From the FDA to Enter Phase I Clinical Trials for Their Polo Like Kinase (PLK) Inhibitor
NERVIANO, Italy, May 13 /PRNewswire/ -- The FDA has approved an
Investigational New Drug (IND) application by Nerviano Medical Sciences to
begin a phase I clinical study with its selective PLK-1 small molecule
inhibitor for the treatment of cancer. PLK-1 is a mitotic kinase required for
Shire and GlaxoSmithKline Enter Agreement to Co-promote VYVANSE(R) (lisdexamfetamine dimesylate) CII for the Treatment of Adults With ADHD
PHILADELPHIA, March 31 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP,
NASDAQ: SHPGY ), the global specialty biopharmaceutical company, today
announced a co-promotion agreement with GlaxoSmithKline plc (NYSE: GSK ) for
VYVANSE(R) (lisdexamfetamine dimesylate) capsules CII with the aim of
NovaBay and Galderma Enter Into Global Agreement to Develop and Commercialize NovaBay's Novel Aganocide Drugs for Major Dermatological Conditions
- Up to $50 Million Potential Milestones plus Double Digit Royalties on Future Sales -
- Company to Host Conference Call at 11:00 a.m. ET Today -
EMERYVILLE, Calif., March 25 /PRNewswire-FirstCall/ -- NovaBay Pharmaceuticals, Inc. (NYSE Amex: NBY ), a mid-stage biopharmaceutical comp...
Enerkem announces plans to enter the United States with next-generation biofuels project in Mississippi
Project will allow the recycling and conversion of 60% of Three Rivers
region's waste material
MONTREAL, March 19 /PRNewswire/ - Enerkem Inc., a leading advanced biofuels and green chemicals technology company, today announced its plans to build and operate a second-generation biofuels prod...
Shire to Enter European ADHD Market With the Acquisition of EQUASYM(R) IR and XL
PHILADELPHIA and DUBLIN, February 20 /PRNewswire-FirstCall/ -- Shire plc
(LSE: SHP, NASDAQ: SHPGY ), the global specialty biopharmaceutical company,
announces that it has signed an agreement with UCB to acquire the worldwide
rights to EQUASYM(R) IR and XL (methylphenidate hydrochloride) (exc...
Romark and Chugai Pharmaceutical Enter Into Exclusive Licensing Agreement for Nitazoxanide in Japan
Chugai Pharmaceutical Gains Rights to Develop and Market Nitazoxanide for the Treatment of Chronic Hepatitis C
TAMPA, Fla., Feb. 17 /PRNewswire/ -- Romark Laboratories, a privately held biopharmaceutical company, and Chugai Pharmaceutical Co. Ltd., a member of the Roche Group, today announced...
ConjuChem and Novozymes Enter Long-Term Supply Agreement for Recombumin(R) use in PC-DAC(TM):Exendin-4
- Additional Pipeline Product Agreement Executed to Support ConjuChem's
R&D Efforts -
MONTREAL and BAGSVAERD, Denmark, Dec. 3 /PRNewswire-FirstCall/ - ConjuChem Biotechnologies Inc. (TSX:CJB) and Novozymes Biopharma UK Ltd., a subsidiary of Novozymes A/S (LSE:NVZ) announce...
IDRI and Immune Design Corp. Enter License Agreement on GLA Vaccine Adjuvant
SEATTLE, Nov. 20 /PRNewswire/ -- IDRI (Infectious Disease Research
Institute) and Immune Design Corp. announced today that they have entered into
an agreement pursuant to which Immune Design Corp. is granted a worldwide
exclusive license for the research, development, and commercialization of
MonoSol Rx and Midatech Group Enter Collaboration Agreement to Unite Nanoparticle and Thin Film Drug Delivery Technologies
Potential to Develop New Oral Drug Candidates with Superior Efficacy,
Safety, Convenience, and Commercial Potential
WARREN, N.J. and OXFORDSHIRE, England, Nov. 3 /PRNewswire/ -- MonoSol
Rx, the developers of PharmFilm(R) technology and a drug delivery company
specializing in dissolving thin f...
NeoStem, Inc. to Enter the Regenerative Medicine Market in Asia
NEW YORK, Nov. 3 /PRNewswire-FirstCall/ -- NeoStem, Inc. (Amex: NBS ),
which is pioneering the pre-disease collection, processing and long-term
storage of adult stem cells for future medical need, announced today that
it has agreed to acquire a Hong Kong corporation, whose wholly-owned
Lilly and Amylin Enter Into Supply Agreement for Exenatide Once Weekly
Lilly to Pay Amylin $125 Million and Extend $165 Million Line of Credit to Amylin
SAN DIEGO and INDIANAPOLIS, Oct. 21 /PRNewswire-FirstCall/ -- Amylin
Pharmaceuticals, Inc. (Nasdaq: AMLN ) and Eli Lilly and Company (NYSE: LLY )
today announced they have entered...
Radiation Therapy Oncology Group and US Oncology Enter Collaboration to Increase Patient Access to National Clinical Trials
Collaboration Brings Cooperative Group Level Radiation Therapy Trials to US Oncology Affiliates' Patients for First Time
HOUSTON, Oct. 16 /PRNewswire/ -- The Radiation Therapy Oncology Group
(RTOG) and US Oncology, Inc. today announced they have entered into a
collaboration to incre...
Neptune Technologies and Marine Life Sciences enter worldwide distribution alliance with Weider Global Nutrition
--First market launch for Neptune Technologies in FUNCTIONAL FOOD market-- LAVAL, QC, Sept. 25 /PRNewswire-FirstCall/ - Neptune Technologies &
Bioressources Inc. ("Neptune") (NASDAQ.NEPT - TSX.V.NTB) reported today
that it entered a worldwide alliance with Mari...
St. Joseph's Hospital and InNexus Biotechnology Enter Collaborative Partnership
- Focusing on Development of Treatments For Women with Endometriosis -
PHOENIX and BRITISH COLUMBIA, Canada, Sept. 19 /PRNewswire-FirstCall/
-- St. Joseph's Hospital and Medical Center, part of Catholic Healthcare
West, one of the largest healthcare systems in the West with 42 hospitals
TVM Capital, Signet Healthcare Partners and Paul Capital Healthcare Enter into euro 26 Million Financing of SpePharm
NEW YORK, MUNICH, Germany and AMSTERDAM, Netherlands, Aug. 21
/PRNewswire/ -- Paul Capital Healthcare and SpePharm Holding, B.V., the
pan-European specialty pharmaceutical company, today announced that they
have entered into a euro 10 million revenue interest acquisition financing
Affitech and Omeros Enter Into Antibody Discovery and Development Agreement
SEATTLE and OSLO, Norway, Aug. 19 /PRNewswire/ -- Omeros Corporation, a
Seattle-based clinical-stage biopharmaceutical company, and Affitech AS, a
Norwegian human antibody therapeutics company, today announced that they
have entered into an agreement for the discovery and development of fully
Rosetta Genomics Announces Three New Diagnostic Tests to Enter Development
New Development Programs to Include Response Prediction to Ovarian Cancer Treatment, Predicting Risk of Gastric Cancer Recurrence, and Differentiation of Small Cell From Non-Small Cell Lung Cancer
In Addition, the Company has Identified Unique microRNA Biomarkers in the
Serum of Colon ...
SomaLogic and Otsuka Enter Into Research Collaboration
Focusing On Diagnostic Products and Target Validation
BOULDER, Colo., May 9 /PRNewswire/ -- SomaLogic, Inc. announced today
that SomaLogic and Otsuka Pharmaceutical Co., Ltd. entered into a
collaboration agreement to use SomaLogic's proprietary aptamer technology
to discover and devel...
University Hospitals Case Medical Center, Cleveland, USA and Cardialysis BV, Rotterdam, the Netherlands Enter Strategic Alliance to Found Cardialysis Cleveland
CLEVELAND, Illinois and ROTTERDAM, The Netherlands, May 9 /PRNewswire/
-- University Hospitals Case Medical Center and Cardialysis BV today
announced that the Companies have the intention to found Cardialysis
Cleveland to provide combined clinical drug development and medical imaging
American Oriental Bioengineering and China Aoxing Pharmaceutical Enter Into Strategic Alliance
- Joint Effort to Capitalize on China's Narcotic and Pain-Management Market Opportunity -
NEW YORK, April 15 /PRNewswire-FirstCall/ -- American Oriental
Bioengineering, Inc. (NYSE: AOB ), a leading marketer, distributor and
manufacturer of pharmaceutical and healthca...
ETEX and LifeNet Health, Inc. Enter Agreement
CAMBRIDGE, Mass., March 3 /PRNewswire/ -- ETEX Corporation, an advanced
biomaterials company, announced today that it has entered into a supply
agreement with LifeNet Health, Inc.
Under the agreement, LifeNet Health will provide ETEX with
Demineralized Bone Matrix (DBM) powder to be mixed wi...
Sigma-Aldrich and MorphoSys Enter Into a Collaboration and Licensing Agreement for Recombinant Research Antibodies
AbD Serotec will use proprietary technology to generate antibodies against novel research targets provided by Sigma-Aldrich
MUNICH, Germany and ST. LOUIS, Feb. 27 /PRNewswire-FirstCall/ --
Sigma-Aldrich(TM) (Nasdaq: SIAL ) and MorphoSys AG (Frankfurt Stock
Exchange: MOR; Prime Stand...
Energy Conversion Devices and United Solar Ovonic Enter Into New $55 Million Secured Credit Facility Agreements
ROCHESTER HILLS, Mich., Feb. 5 /PRNewswire-FirstCall/ -- Energy
Conversion Devices, Inc. (ECD) (Nasdaq: ENER ) announced today that its
wholly owned subsidiaries, United Solar Ovonic LLC and United Solar Ovonic
Corporation, have entered into a new secured revolving credit facility,
with an ag...
ChemDiv and Achaogen Enter Into a Discovery Collaboration
SAN DIEGO, Jan. 29 /PRNewswire/ -- ChemDiv, Inc., a leading
chemistry-driven global contract research organization, has announced today
that it has entered into a discovery collaboration with Achaogen, Inc.,
South San Francisco, CA. Applying its expertise in medicinal and synthetic
Chindex's United Family Hospitals and Clinics and NBC Enter into Healthcare Services Agreement
NBC to Have Access to Chindex's Medical Services During its Preparation and Coverage of the Beijing Olympics, August 8-24, 2008
BETHESDA, Md., Jan. 23 /Xinhua-PRNewswire/ -- Chindex International,
Inc. (Nasdaq: CHDX ) a leading independent American provider of Western
Bookham to Enter Biomedical Illumination Market
Proven filter technology to underpin compact LED multiplexing module
SANTA ROSA, Calif., Jan. 14 /PRNewswire-FirstCall/ -- Bookham, Inc.
(Nasdaq: BKHM ), a leading provider of optical components for industrial
applications, is to enter
the biomedical market with its ZoroLight(TM) LED
Palomar and Q-MED AB Enter Into International Distribution Agreement
Q-MED AB to distribute Palomar products outside North America
BURLINGTON, Mass., Jan. 9 /PRNewswire-FirstCall/ -- Palomar Medical
Technologies, Inc. (Nasdaq: PMTI ), a leading researcher and developer of
light-based systems for cosmetic treatments, today announced the execution
of an int...
Genmab A/S - R1507 Antibody to Enter Phase II Study to Treat Sarcoma
Summary: Genmab's Partner, Roche has Initiated a Phase II study of R1507 for the Treatment of Sarcoma
COPENHAGEN, Denmark, December 20 /PRNewswire-FirstCall/ -- Genmab A/S
(OMX: GEN) announced today that its partner, Roche has initiated a Phase II
clinical study of R1507 f...
Good Neighbor Pharmacy Joins with Diversified Racing Solutions to Enter NASCAR Nationwide Series in 2008
Driver Chris Bristol to Pilot Chevrolet Car
VALLEY FORGE, Pa., Dec. 17 /PRNewswire/ -- Good Neighbor Pharmacy(R)
(GNP) today announced that it has joined with Diversified Racing Solutions
(DRS) to enter
the NASCAR(R) Nationwide Series in 2008 with the goal of
competing in the NAS...
Alba Therapeutics Corporation and Shire plc Enter Into $325 Million ex-US, ex-Japan Licensing Agreement to Develop and Commercialize AT-1001
BALTIMORE, Dec. 14 /PRNewswire/ -- Alba Therapeutics Corporation
announced today that it has entered into a strategic collaboration with
Shire plc (LSE: SHP, Nasdaq: SHPGY, TSX: SHQ), to jointly develop AT-1001,
Alba's lead inhibitor of barrier dysfunction in various gastrointestinal
STALLERGENES and Protein' eXpert Enter Into a Partnership for Producing Mites Recombinant Allergens
ANTONY, GRENOBLE France, December 13 /PRNewswire-FirstCall/ --
STALLERGENES S.A and Protein'eXpert S.A. announce they have signed a
partnership agreement for developing and pharmaceutically producing mites
The partnership is part of the STALLERGENES "Enhanced Allerg...
Fourth Genmab Antibody Developed Under Roche Collaboration to Enter Clinic
Summary: An IND has Been Filed With the FDA for the Fourth Genmab Antibody Developed Under the Company's Collaboration with Roche.
COPENHAGEN, December 12 /PRNewswire-FirstCall/ -- Genmab A/S (OMX: GEN)
announced today that an Investigational New Drug application (IND) for a